In a significant move aimed at strengthening drug safety and curbing misuse, the Union Health Ministry has amended regulations to make doctor’s prescriptions mandatory for the purchase of cough syrups and other syrup-based medicines across India. The decision effectively ends the over-the-counter sale of these products, marking one of the biggest changes to pharmaceutical retail rules in recent years.
Under the revised rules, syrup-based medicines have been removed from the exemption category under Schedule K of the Drugs Rules, 1945. Previously, certain cough syrups could be sold without the same level of regulatory oversight as prescription medicines, particularly in smaller villages where access to licensed pharmacies was limited. With the amendment now in force, consumers will need a valid prescription from a registered medical practitioner before purchasing such medicines.
The government’s decision comes amid growing concerns over the misuse of cough syrups and increased scrutiny of India’s pharmaceutical sector. Health experts have repeatedly warned against self-medication, especially in cases of persistent coughs where underlying medical conditions may go undiagnosed. Doctors have welcomed the move, arguing that tighter controls will encourage safer and more responsible use of medications.
The regulation also follows a series of controversies surrounding contaminated cough syrups manufactured in India. Since 2022, India-made cough syrups have been linked to the deaths of more than 140 children in several countries, prompting global concern and putting pressure on regulators to strengthen oversight of the pharmaceutical industry. Authorities have since conducted extensive inspections of manufacturing facilities and introduced additional safeguards to improve quality standards.
According to the Health Ministry, the latest amendment is intended to ensure safer distribution practices and greater compliance with regulatory standards. While tablets, pills and lozenges continue to remain under existing exemptions, syrup-based medicines will now be subject to stricter monitoring and controlled sales through licensed pharmacies.
The move is expected to impact both consumers and retailers, particularly in rural areas where cough syrups were often purchased directly from local vendors. However, public health experts believe the benefits outweigh the inconvenience, arguing that medical supervision is essential to prevent misuse and improve patient safety.
With the new rules now in effect, India’s pharmaceutical regulatory framework has taken another step towards tighter oversight, signalling the government’s intent to place patient safety and responsible medicine use at the centre of healthcare policy.
